StockData
Lucid Diagnostics Inc. logo

Lucid Diagnostics Inc. (LUCD) stock

LUCDNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 12, 2026Score 7/3078% above fair value
$0.45+0.03 (+7.88%)

Close on Nov 13, 2026Market cap $91.28MP/E –Yield –

Lucid Diagnostics operating margin

Operating margin is operating income as a percentage of revenue.

Lucid Diagnostics's operating margin for the twelve months ending Sep 30, 2026 was -941.7%. For fiscal 2025 it was -1054.8%, against -1059.6% the year before. The highest annual figure on record is -1054.8% in fiscal 2025.

Annual operating margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-1054.8%+4.8
FY2024Dec 31, 2024-1059.6%+937.1
FY2023Dec 31, 2023-1996.8%+12923.9
FY2022Dec 31, 2022-14920.7%−9436.9
FY2021Dec 31, 2021-5483.8%–

Quarterly operating margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q3 FY2026Sep 30, 2026-1020.4%−49.4
Q2 FY2026Jun 30, 2026-868.5%+110.4
Q1 FY2026Mar 31, 2026-964.5%+543.6
Q4 FY2025Dec 31, 2025-931.6%+102.3
Q3 FY2025Sep 30, 2025-971.0%+26.8
Q2 FY2025Jun 30, 2025-978.8%+167.9
Q1 FY2025Mar 31, 2025-1508.1%−430.0
Q4 FY2024Dec 31, 2024-1033.8%+67.4
Q3 FY2024Sep 30, 2024-997.8%+423.4
Q2 FY2024Jun 30, 2024-1146.7%+6138.8
Q1 FY2024Mar 31, 2024-1078.1%+2132.0
Q4 FY2023Dec 31, 2023-1101.3%+12269.3
Q3 FY2023Sep 30, 2023-1421.2%+17495.9
Q2 FY2023Jun 30, 2023-7285.5%−792.9
Q1 FY2023Mar 31, 2023-3210.1%+536.9
Q4 FY2022Dec 31, 2022-13370.5%−10115.5
Q3 FY2022Sep 30, 2022-18917.1%–
Q1 FY2022Mar 31, 2022-6492.6%–
Q4 FY2021Dec 31, 2021-3747.0%–
Q3 FY2021Sep 30, 2021-3255.0%–

More Lucid Diagnostics figures

See a number that looks wrong?